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INTRODUCTION 
The growing interest in the burden of chronic and 
disabling illnesses, which includes mental disorders, 
has increased in the last 30 years. This was followed by 
a rapid change in health needs of the world population 
over the next two decades. In developing countries for 
instant, non-communicable diseases, such as mental 
disorders and heart disease, will overtake infectious 
disease and malnutrition as the leading causes of 
morbidity. By the year 2020, death due to non-
communicable diseases is also expected to increase to 
seven out of every ten deaths, as compared with less 
than half 30 years ago. It is estimated that death from 
non-communicable diseases will jump from 28.1 
million per year in 1990 to 49.7 million in 2020, an 
increase of 77% [1].    
 The majority of these changes are expected to 
occur in developing countries as compared to developed 
and underdeveloped countries, due to increased life 
span and rapid aging processes.  With a significant fall 
of birth rate in most developed countries; the ratio of 
adults to children will be increased and subsequently the 
prominent health problem will be those of adults’ 
because less number of children are affected. These 
changes, termed ‘epidemiological transition’, has been 
observed in a few countries in Asia and South America. 
More countries are expected to experience this 
phenomenon in the next few years [1]. 
Mental Health in Malaysia 
The National Health and Morbidity Survey (NHMS), 
has been an important platform for monitoring the 
health of the population in Malaysia. The objectives of 
the NHMS are to provide community-based data on the 
pattern of common health problems, health service 
utilisation, and health expenditure in the community. 
The prevalence of mental health problems among adults 
have steadily increased in the last few years. It increased 
from 10.7% in 1966, to 11.2% in 2006, to 29.2% in 
2015 (NHMS-V) [2]. With the current prevalence of 
29.2%, every three in ten adults aged 16 years and 
above will have some sort of mental health problem(s) 
in the course of their lives; which means that 4.2 million 
The Burden of Mental Illness: An Emerging Global Disaster 
 
Mohd Razali Salleh 
 
Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia 
 
 
 
Faculty Of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia 
 
 
ABSTRACT 
The global burden of disease (GBD) has shifted from communicable to non-communicable 
diseases, and from premature death to years live with disabilities (YLDs) over the past 30 years. 
Mental and substance use disorders constitute a major component in the scenario of the global 
health with a significant impact on the global burden of disease, especially in the developing 
countries. The 1990 GBD study listed depression as the fourth common cause of global burden 
of disease; while lower respiratory infections, diarrheal diseases and conditions arising during 
perinatal period are top in the list. In GBD 2000 study depressive disorders climbed to the third 
place, however still behind lower respiratory infections and diarrheal diseases. The subsequent 
2010 GBD study ranked depression in the second place of the global disability burden, and are 
also considered as a major contributor to the burden of suicide and ischaemic heart disease. 
The WHO predicted that depressive disorders will be the leading cause of global burden in 
2030. 
 
 
KEYWORDS: Global burden of disease (GBD), Mental illnesses, Substance use disorders 
 
 
 
 
 
 
 
 
Received 
16th April 2018 
Received in revised form 
7th May 2018 
Accepted 
21st May 2018 
 
 
Corresponding author: 
Mohd Razali Salleh 
Discipline of Psychological & 
Behavioral Medicine (PBM), 
Faculty of Medicine, 
Universiti Teknologi MARA, 
47000 Sungai Buloh,  
Selangor, Malaysia. 
Email: razali6403@salam.uitm.edu.my 
 
Burden of Mental Illness 
 
 
Vol 3(1) (2018) 5-12 | jchs-medicine.uitm.edu.my | eISSN 0127-984X                                                                                    6                                                                            
                  
 
out of 14.4 million Malaysians aged 16 and above will 
suffer from a form of mental illness. Although the 
difference was not significant, the prevalence in females 
was slightly higher than in males. The at risk groups 
include females, younger adults, and adults from low 
income families. The overall prevalence of mental 
health problem among children (five to 15 years old) 
was 12.1%. The prevalence was as follows: peer 
problems (32.5%), conduct problems (16.7%), 
emotional problems such as anxiety and depression 
(15.7%), poor-social skills (11.2%), and hyperactivity 
(4.6%). Risk factors for children are boys, younger age 
group, and from rural areas. 
 Although the NHMS-V [2] did not assess the 
prevalence of any specific mental illness, anxiety and 
depression are among the common mental health 
problems in the community across social classes. In 
Malaysia, depression affects approximately 2.3 million 
people at some point in their lives [3]. Depression is a 
debilitating illness, and has become a leading cause of 
morbidity globally. The lifetime occurrence of 
depression in any country is between 8 and 10%. The 
World Bank predicted that 340 million people will 
suffer from depression by 2020; and by 2030 depression 
will be the most disabling disease, as it will have the 
highest number of days lost due to a disability [4].  
 There is no exact figure on the prevalence of 
depression in Malaysia. In his review, Ng (2014) [5] 
found that the prevalence of depression in Malaysia was 
estimated to be between eight and 12%. The figures 
were higher among women of low socio-economic 
background or those with medical comorbidity. 
According to Firdaus and Tian (2011) [6], the 
prevalence in the primary care setting was 6.7% to 
14.4%; however, it is higher in the elderly and among 
those with co-morbid illnesses. Meanwhile, Malaysian 
life expectancy has been rising lately. Life expectancy 
at birth in 2015 was 72.5 years for males and 77.4 years 
for females. As Malaysia progresses towards an ageing 
nation, the population over 65 should come to 15% of 
the population by 2035 [7]. Thus, we expect that larger 
numbers of the elderly population will be suffering from 
depression as a result of longer life span; this is in 
accordance with the WHO prediction that major 
depressive disorder will be the leading cause of burden 
in 2030 [4].  
Quantifying the Global Burden of Illness and 
Disability 
Although diseases such as neuropsychiatric disorders 
and chronic mental illnesses are considered as serious 
illnesses, the mortality rate is low. Therefore, it is 
important to have a single data or a common parameter 
to measure for survival and health status of the overall 
population for the benefit of health policy makers. In 
this aspect, two vital parameters are required: premature 
death and disability. The previous research agrees that 
the appropriate parameter is time (in years) lost through 
premature death, and time (in years) lived with a 
disability. A range of time-based variation 
measurements has been developed world-wide; the so-
called quality-adjusted life year (QALY). For the 
Global Burden of Disease (GBD) Study, an 
internationally standardised form of the QALY was 
used, known as the disability-adjusted life year (DALY) 
[8]. 
 DALYs are population health measures that 
combined mortality and morbidity rates in a single 
measure. DALYs are also defined as years of healthy 
life lost. The DALY expresses years of life lost to 
premature death (YLL) and years lived with a disability 
(YLD) or poor health of specified severity and duration. 
The effect of fatal cases (disease or injury) is captured 
by YLL (years of life lost due to premature mortality), 
while YLD (years of lived with disability) captures the 
future health consequences in terms of sequelae of 
diseases, injuries, or accidents that were not fatal.To 
calculate total DALYs for a given condition in a 
population; YLL and YLD for that condition each must 
be estimated first, and then totalled [8]. One DALY 
represents the loss of a healthy year of life. 
WHO Global Burden of Disease (GBD) Study 
1990 and 2000    
Historically the GBD enterprise was started in early 
1990s (GBD 1990) [1, 9]. The study was commissioned 
by The World Bank; while the founders of the study 
were Dr Christopher Murray and Dr Alan Lopez. It then 
grew to become a global effort in GBD 2010 study.  The 
GBD study utilised the most comprehensive effort to 
analyse and quantify the world health problems. The 
Disease Burden Unit of WHO continuously updated 
and published GBD findings. The GBD has helped 
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transform health care policy in numerous countries, and 
has greatly influenced research, policy and education. 
The GBD study is used by numerous organisations as a 
primary source of data information and analysis; 
including The World Bank and U.S National Institutes 
of Health [9].  
 The Global Burden of Diseases, Injuries, and 
Risk Factors Study 1990 (GBD 1990) [1] provides a 
comprehensive reference for policy-makers of the 
world current and future health needs for the first time. 
The researchers involved in this ambitious five-year 
project developed a new approach of measuring health 
status. Their method quantifies not merely the number 
of death but also the impact of premature death and 
disability on a population; and combines these into a 
single unit of measurement or parameter of the overall 
"burden of disease" on the population. The series also 
presents the first estimates of the proportion of mortality 
and disability that can be attributed to certain risk 
factors for any illness throughout the world. 
 Due to limited data available, policy makers 
had difficulty to plan for future health services. There 
was no single measurement or parameter that combined 
the fatal and non-fatal outcome of disease or injury from 
the exposure to multiple major health risks prior to the 
first GBD study. Most of the available epidemiological 
data fails to capture the impact of non-fatal outcomes of 
chronic illness and injury, such as dementia or blindness 
on population health. The traditional health statistics 
also do not allow policy-makers to compare the relative 
cost-effectiveness of different interventions, such as the 
treatment of ischaemic heart disease versus long term 
care for schizophrenia. The GBD set out to address 
these problems by incorporating non-fatal conditions 
into assessments of health status; and measurement of 
disease and injury burden in a single parameter that can 
also be used to assess the cost-effectiveness of the 
interventions. It is an exceptional effort to introduce a 
common metric or parameter to summarise the disease 
burden and major risk factors that cause those health 
outcomes according to International Classification of 
Diseases (ICD) diagnoses. 
  The 1990 GBD [1] study had a significant 
contribution in analysing and assessing the impact of 
damage from diseases, injuries and risk factors of the  
 
 
 
Table 1 Change in range order of disease burden for 15 leading 
causes, worldwide, 1990-2020  
1990   2020 
Disease / Injury     Rank Rank   Disease / 
Injury 
Lower respiratory 
infection   
1 1 Ischaemic heart 
disease 
Diarrheal disease                                  2 2 Unipolar major 
depression 
Conditions arising 
during perinatal 
period                  
3 3 Road traffic 
accidents 
Unipolar major 
depression 
4 4 Cerebrovascular 
disease 
Ischaemic heart 
disease 
5 5 COPD 
Cerebrovascular 
disease 
6 6 Lower 
respiratory 
infection   
Tuberculosis 7 7 Tuberculosis 
Measles 8 8 War 
Road traffic 
accidents 
9 9 Diarrheal disease                                  
Congenital 
abnormalities 
10 10 HIV 
Malaria 11 11 Conditions 
arising during 
perinatal period                  
COPD 12 12 Violence 
Fall 13 13 Congenital 
abnormalities 
Iron-deficiency 
anaemia 
14 14 Self-inflicted 
injuries 
Protein-energy 
malnutrition  
15 15 Trachea, 
bronchus and 
lung cancers 
Reference [1]: World Health Organization 1996 
 
world population at large. Various governments and 
non-government agencies plan their strategic 
allocations in health resources and prevention programs 
based on the finding of this study. The results of the 
study confirmed that many are suffering from non-
communicable diseases and injuries that significantly 
contribute to health burden, especially in a rapidly
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Table 2 Ten leading causes of burden of disease, worldwide, 2004 and 2030 
Reference [10]: World Health Organization 2008 
industrialising region in Asia and developing countries. 
Neuropsychiatric disorders were major causes of 
disability as measured by DALYs; however, they were 
misleading when measured by mortality alone, as the 
mortality rate due to these illnesses is low.   
 Table 1 [1] and Table 2 [10] summarise the 
leading causes of burden and projected burden from 
GBD 1990 and 2000 study respectively. The GBD 1990 
ranked depressive disorders as the fourth leading cause 
of burden worldwide (equivalent to 3.7% of all 
DALYs), after lower respiratory infections, diarrhoeal 
diseases, and conditions arising during the perinatal 
period; and one of the leading causes of years lived with 
disability (YLD), accounting for 10.7% of total YLDs.   
 In 2001, the WHO embarked on a new 
assessment of the Global Burden of Disease for the year 
2000 (GBD 2000) [10] using new epidemiology 
parameters. Parts of the findings were analysed and 
presented in the WHO Report (2002, 2008) [10, 11]. 
The data also had been published by Mathers et al. 
(2002) [12]) and Ustun et al. (2004) [13]). The GBD 
2000 found that depressive disorders were the third 
leading cause of burden (equivalent to 4.3% of all  
 
Table 3 DALYs of neuropsychiatric disorders in middle-income 
countries, 2004 
 Neuropsychiatric disorders DALYs 
(thousands) 
 
1 Unipolar depressive disorders 28,983 
2 Alcohol use disorders 14,853 
3 Schizophrenia 8,429 
4 Bipolar affective disorder 7,041   
5 Alzheimer’s and other 
dementias 
4,772 
6 Drug use disorders 3,664 
7 Migraine 3,512 
8 Panic disorder 3,348 
9 Epilepsy 3,201 
10 Obsessive compulsive disorders 2,484 
11 Post-traumatic disorders 1,663 
12 Insomnia (primary) 1,485 
13 Multiple Sclerosis 730 
14 Parkinson disease 670 
Reference [10]: World Health Organization 2008 
2004 % of 
total 
DALYs 
Rank Rank % of 
total 
DALYs 
2030 
Disease/Injury     Disease/Injury 
Lower respiratory infection 6.2 1 1 6.2 Unipolar depressive disorders        
Diarrheal disease                               4.8 2 2 5.5 Ischaemic heart disease                   
Unipolar depressive disorders        4.3 3 3 4.9 Road traffic accidents                       
Ischaemic heart disease                   4.1 4 4 4.3 Cerebrovascular disease                  
HIV/AIDS 3.8 5 5 3.8 COPD 
Cerebrovascular disease                  3.1 6 6 3.2 Lower respiratory infection 
Prematurity and low birth               2.9 7 7 2.9 Hearing loss, adult onset                  
Birth asphyxia & birth trauma         2.7 8 8 2.7 Refractive errors                                
Road traffic accidents                       2.7 9 9 2.5 HIV/AIDS 
Neonatal infection & others            2.7 10 10 2.3 Diabetes mellitus 
COPD 2.0 13 11 1.9 Neonatal infection & others            
Refractive errors                                1.8 14 12 1.9 Prematurity & low birth weight 
Hearing loss, adult onset                  1.8 15 15 1.9 Birth asphyxia & birth trauma 
Diabetes mellitus                               1.3 15 18 1.6 Diarrheal diseases             
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DALYs), after lower respiratory infections and 
diarrhoeal diseases. It was also the leading cause of 
disability, responsible for 13.4% of YLDs in women 
and 8.3% in men. By the year 2030, it is predicted that 
depression will be the most burdening illness 
worldwide [10]. 
 Unipolar depression was the largest disease 
burden among neuropsychiatric disorders in middle-
income countries in 2004, accounting for 28,983 
DALYs. The other five top burdens in the list are 
bipolar disorder, schizophrenia, epilepsy, alcohol use 
disorder, and Alzheimer disease and other dementia 
(Table 3) [10]. Although the disability burden of 
neuropsychiatric disorders is almost the same for males 
and females, the major contributing causes are different. 
Although depression is the leading causes of burden for 
both males and females, the burden is 50% higher in 
females than males. The GBD 2000 study also showed 
that in all the regions, neuropsychiatric disorders are the 
most important causes of disability, accounting for 
around one third of YLDs among adults aged 15 years 
and above. 
Mental and Substance Use Disorders in GBD 
2010 
The Global Burden of Disease Study 2010 (GBD 2010) 
[9] is the largest ever systematic effort to quantify the 
global distribution and causes of a wide array of major 
diseases, injuries, and health risk factors. The GBD 
2010, which was launched in 2007 is a consortium of 
seven partners and it is co-sponsored by Bill & Melinda 
Gates Foundation. It celebrated the 20th anniversary in 
Seattle, USA recently on 25-27th September 2017 [14]. 
Although the earlier work of GBD was conducted 
mainly by researchers from Harvard and the World 
Health Organization (WHO) in a relatively small scale; 
the GBD 2010 grew extensively in a bigger scale as a 
global effort. It involved nearly 500 experts in 
epidemiology, statistics and other relevant disciplines in 
50 countries throughout the world. The work had been 
highlighted in The Lancet which published seven 
papers, commentaries and extensive web appendices 
[14]. 
 The GBD 2010 was a comprehensive analysis 
of burden, with an expanded number of mental and 
substance use disorders as well as improved definitions, 
data collection, and methodology. The inclusion of 
childhood disorders was especially important in regions 
such as Africa, where up to 40% of the population are 
children. The burden estimation techniques were 
changed substantially in GBD 2010. Among the notable 
changes are, prevalence rather than incidence based and 
YLDs were estimated without age weighting and 
discounting. The GBD 2010 also provides new 
estimates of years of life lost to premature mortality 
(YLL), years lived with disability (YLD), and 
disability-adjusted life years (DALY). It is developed 
from the weakness of 1990 and 2004 GBD study [10].  
 Throughout the world in 2010, the mental and 
substance use disorders constituted 183.9 million 
DALYs (95% UI 153.5-216.7 million) or 7.4% of the 
total burden. On the whole, mental and substance use 
disorders were the leading causes of YLDs and the fifth 
highest disorder of global DALYs (Table 4). Mental and 
substance use disorders were also the main cause of 
non-fatal burden of disease in 2010, which accounted 
for 175.3 million (95% UI 144.5-207.8 million) YLDs 
(Table 5) [15]. Depressive disorders contributed most 
of the non-fatal burden of mental and substance use 
disorders, followed up by anxiety disorders, drug use 
disorders, and schizophrenia. Among the mental and 
substance use disorders group, depressive disorders 
accounted for most DALYs, followed by anxiety 
disorders, drug use disorders, and alcohol use disorders 
(Table 5). While eating disorders, childhood 
behavioural disorders, and pervasive developmental 
disorders, which were assessed for the first time in GBD 
2010, estimates contributed about 9% of DALYs 
accounted for by mental and substance use disorders 
[13, 16-17]. 
 In 2010 Major Depressive Disorder (MDD) 
constituted 8.2% of the global YLDs; it is also the 
second highest in the list of global disability and 
eleventh leading cause of global burden. Another 
depressive illness which is less severe, dysthymia 
accounted for 1.4% of global YLDs.  Women suffered 
a higher burden of depression as compared to men, 
while the adults of working age group formed the 
largest proportion of YLDs. Between 1990 and 2010, 
the global burden of depression increased by 37.5% due 
Burden of Mental Illness 
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to population growth and aging. The GBD 2010 
demonstrated that MDD contributed additional burden 
of 16 million DALYs and 4 million DALYs when it 
implicated with a risk factor for suicide and ischaemic 
heart disease, respectively. This additional burden  
contributed to the increased of overall burden of 
depression to 3.8% of global DALYs. The 2010 GBD 
study concluded that depressive disorders are a leading 
direct cause of the global disease burden and depression 
also contributes to additional burden related to suicide 
and ischaemic heart disease [18, 19]. 
Table 4 Proportion of YLDs, YLLs, and DALYs explained by the ten leading causes of total burden in 2010 
  Proportion of total 
DALYs (95% UI) 
Proportion of total 
YLDs (95% UI) 
Proportion of total 
YLLs (95% UI) 
 
1. Cardiovascular and circulatory diseases 
 
11.9% (11.0-12.6) 2.8% (2.4-3.4) 15.9% (15.0-16.8) 
2. Diarrhoea, lower respiratory infections, meningitis, 
and infectious diseases  
 
11.4% (10.3-12.7) 2.6% (2.0-3.2) 15.4% (14.0-17.1) 
3. Neonatal disorders 
 
8.1% (7.3-9.0) 1.2% (1.0-1.5) 11.2% (10.2-12.4) 
4. Cancer 
 
7.6% (7.0-8.2) 0.6% (0.5-0.7) 10.7% (10.0-11.4) 
5. Mental and substance use disorders 
 
7.4% (6.2-8.6) 22.9 (18.6-27.2) 0.5% (0.4-0.7) 
6. Musculoskeletal disorders 
 
6.8% (5.4-8.2) 21.3 (17.7-24.9) 0.2% (0.2-0.3) 
7. HIV/ AIDS and tuberculosis 
 
5.3% (4.8-5.7) 1.4% (1.0-1.9) 7.0% (6.4-7.5) 
8. Other non-communicable disease 
 
5.1% (4.1-6.6) 11.1% (8.2-15.2) 2.4% (2.0-2.8) 
9. Diabetes, urogenital, blood and endocrine disease 
 
4.9% (4.4-5.5) 7.3% (6.1-8.7) 3.8% (3.4-3.3) 
10. Unintentional injuries other than transport injuries 
 
4.8% (4.4-5.3) 3.4% (2.5-4.4) 5.5% (4.9-5.9) 
DALYs=disability-adjusted life-years. YLDs=years lived with disability. YLLs=years of life lost. 
Reference [15]: Lancet 2013 
 
 
Table 5 The percentages of YLDs, YLLs and DALYs of each mental and substance use disorders groups in 2010 
                              Disease YLDs (%) YLLs (%) DALYs (%) 
1 Depressive disorders 42.5 - 40.5 
2 Schizophrenia 7.4 7.1 7.4 
3 Bipolar disorder 7.4 - 7.0 
4 Alcohol use disorders 7.9 44.4 9.6 
5 Drug use disorders 9.4 41.7 10.9 
6 Anxiety disorders 15.3 - 14.6 
7 Pervasive development disorders 4.4 - 4.2 
8 Childhood behavioural disorders 3.5 - 3.4 
9 Eating disorders 1.1 2.4 1.2 
10 Idiopathic intellectual disability 0.6 - 0.6 
11 Other mental disorders 0.6 4.3 0.8 
              DALYs=disability-adjusted life-years. YLDs=years lived with disability. YLLs=years of life lost. 
              Reference (15): Lancet 2013 
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CONCLUSION 
The high burden of depression was one of the key 
findings of the GBD studies. These studies found a 
consistent increased in the burden of depression, as 
shown in GBD 1990, 2000, and 2010 studies. Although 
there were some variations by region, patterns but the 
trends are remarkably similar worldwide. Depressive 
disorders constitute a large proportion of the global 
burden of disease, both in the developed and developing 
countries. The high burden is resulting from the 
combination of a high prevalence of depression, high 
impact on functioning, and early age of onset. These 
results of the GBD studies have provided powerful 
scientific and advocacy support for mental health to 
date. Thus, it is imperative to apply these findings for 
policy-making, planning, and intervention programs.  
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